BeStock  
Stocks › Biotechnology › IMCR

Immunocore IMCR

US equityMarket cap rank #2944Biotechnology
$26.41 −$0.22 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.41 0.00%
Open$26.37
Prev close$26.63
Day range$25.61 – $26.82
Volume546.2K
Market cap$1.36B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership101.0%-1.96 pts vs. prior quarter
Institutions holding153-6 vs. prior quarter
Insider trades (recent)33 buys / 17 sellsNet buying
Short interest15.13% of floatDays to cover 14.2 · as of 30 Oct 2026
Short-sale volume share7.5%5-day average of daily volume

Short-sale volume as % of daily volume

1%7%14%21%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$17.56M (5 inflow days, 15 outflow days).

Net flow by order size, last 20 sessions

−$17.7MSuper+$145.3KBig−$1.4MMid+$1.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.1% of shares outstanding.

Largest holders

  • Wellington Management Group11.07%
  • RTW Investments, LP9.42%
  • PRIMECAP Management Company7.04%
  • Bellevue Asset Management AG5.40%
  • Tang Capital Management, LLC5.13%
  • Point72 Asset Management, L.P.4.29%
  • Acadian Asset Management LLC3.53%
  • Vestal Point Capital, LP3.48%

By investor type

  • Mutual Fund48.95%
  • Hedge Fund47.64%
  • VC/PE Fund1.83%
  • Public Company1.17%
  • Private Company1.01%
  • Government Pension Fund0.38%
  • Individual/Insider0.10%
  • Government0.01%

Reported short interest has fallen from 15.33% to 15.13% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +1,228,159 4.3%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +614,561 3.5%
UBS Asset Management Mutual Fund 2026/Q3 +275,449 0.6%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +164,800 0.5%
Caligan Partners, LP Hedge Fund 2026/Q3 +1,381,317 2.7%
Wellington Management Group Mutual Fund 2026/Q3 +1,015,777 11.1%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +708,803 2.3%
Two Sigma Investments, LP Hedge Fund 2026/Q3 +627,718 3.2%
Braidwell LP Hedge Fund 2026/Q3 +521,327 1.0%
Jones Hill Capital LP Hedge Fund 2026/Q3 +512,856 1.0%
Kynam Capital Management, LP Hedge Fund 2026/Q3 +490,063 2.7%
Fulcrum Asset Management LLP Hedge Fund 2026/Q3 +470,025 0.9%
Marshall Wace LLP Hedge Fund 2026/Q3 +410,601 1.1%
Trails Edge Capital Partners, LP Hedge Fund 2026/Q3 +380,637 2.1%
Millennium Management LLC Hedge Fund 2026/Q3 +359,634 3.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
26 May 2026 John Bell Independent Non-Executive Chairperson Other Derivative Acquisition +27,492 $28.52 27,492
26 May 2026 Kristine Peterson Independent Non-Executive Director Other Derivative Acquisition +27,492 $28.52 27,492
26 May 2026 Roy Steven Herbst Independent Non-Executive Director Other Derivative Acquisition +27,492 $28.52 27,492
26 May 2026 Peter Ratcliffe Independent Non-Executive Director Other Derivative Acquisition +27,492 $28.52 27,492
26 May 2026 William Pao Independent Non-Executive Director Other Derivative Acquisition +27,492 $28.52 27,492
26 May 2026 Siddharth Kaul Independent Non-Executive Director Other Derivative Acquisition +27,492 $28.52 27,492
10 Mar 2026 David Berman Former Officer Intent to Sell (Form 144) -11,832 $32.57 –
17 Feb 2026 Bahija Jallal Chief Executive Officer Intent to Sell (Form 144) -11,474 $32.35 –
17 Feb 2026 Tina Leger Former Chief Human Resources Officer Intent to Sell (Form 144) -1,000 $32.35 –
17 Feb 2026 David Berman Former Officer Intent to Sell (Form 144) -5,965 $32.35 –
17 Feb 2026 Bahija Jallal Chief Executive Officer Derivative Exercise and Sale -11,474 $32.35 12,343
17 Feb 2026 John Goll SVP, Finance & Chief Accounting Officer Derivative Exercise and Sale -698 $32.35 653
17 Feb 2026 Tina Leger Former Chief Human Resources Officer Derivative Exercise and Sale -1,000 $32.35 1,119
17 Feb 2026 David Berman Former Officer Derivative Exercise and Sale -5,965 $32.35 5,859
16 Feb 2026 Bahija Jallal Chief Executive Officer Other Derivative Acquisition +88,573 – 88,573
16 Feb 2026 Bahija Jallal Chief Executive Officer Other Derivative Acquisition +395,066 $32.38 395,066
16 Feb 2026 Bahija Jallal Chief Executive Officer Derivative Exercise and Retained +12,343 – 12,343
16 Feb 2026 John Goll SVP, Finance & Chief Accounting Officer Other Derivative Acquisition +7,411 – 7,411
16 Feb 2026 John Goll SVP, Finance & Chief Accounting Officer Other Derivative Acquisition +21,252 $32.38 21,252
16 Feb 2026 John Goll SVP, Finance & Chief Accounting Officer Derivative Exercise and Retained +653 – 653

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,793,995 15.1% 14.2
15 Oct 2026 7,801,461 15.1% 15.7
30 Sep 2026 7,903,280 15.3% 20.7
15 Sep 2026 7,770,242 15.1% 20.6
31 Aug 2026 7,793,032 15.1% 20.8
14 Aug 2026 7,895,815 15.3% 18.8

Discussion

No comments yet — be the first to weigh in on IMCR.

Sign in to join the discussion.

Scroll to Top